News
In patients without previous skin cancer, BCC incidence per 100 000 patient-years was 342 (95% CI 290 to 402) after anti-TNF and 407 (95% CI 288 to 558) after nbDMARD. HR after anti-TNF adjusted for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback